News
-
-
-
-
-
PRESS RELEASE
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
Gemina Laboratories Ltd shares strategic update for 2024, focusing on revenue streams, partnerships, and new technologies for diagnostics. Company plans new protein production facility and market expansion -
-
-
PRESS RELEASE
Gemina Announces Closing of $910,000 Convertible Note Financing
Gemina Laboratories Ltd. raises $910,000 through non-brokered private placement of unsecured convertible notes for general working capital and corporate purposes. Securities subject to holding period and outside Canada restrictions -
PRESS RELEASE
Gemina Labs Ltd Appoints Stifel as Financial Advisor
-